Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Big effect

A meta-analysis of 16 trials linked a probiotic to a large reduction in eczema severity (SMD –4.24) — but the effect was strain-specific and the dose wasn't reported.

This is a strong signal for Lactobacillus GG in children with food allergies, but the analysis relied on indirect comparisons and the results may not generalize to adults or to other strains like Bifidobacterium bifidum BB-06, which was included but not highlighted as the top performer.

Researchers pooled data from 16 randomized trials involving 502 children with food allergies and found that Lactobacillus GG was the most effective probiotic for reducing eczema severity (measured by SCORAD) and improving quality of life. The analysis also examined other strains, including Bifidobacterium bifidum BB-06, but specific effect sizes for those were not reported. Because the study is a network meta-analysis and doses were not specified, the findings need confirmation in direct head-to-head trials.

Where this fits in the evidence

This is among the first studies we've indexed on Bifidobacterium bifidum BB-06 for Improved Allergic Symptoms — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top